Department for BioMedical Research DBMR, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Department of Respiratory Medicine, Antrim Area Hospital, Northern Health and Social Care Trust, Antrim, Northern Ireland, UK.
Immunol Allergy Clin North Am. 2023 May;43(2):389-410. doi: 10.1016/j.iac.2023.01.004. Epub 2023 Mar 3.
The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease.
新冠病毒 2019 后症状患者（长新冠）的比例对个人和医疗保健系统来说都是一个重大负担。对症状在更长时间内的自然演变和干预措施的影响有更深入的了解，将提高我们对 COVID-19 疾病长期影响的认识。本综述将讨论新冠后间质性肺病的新出现证据，重点关注潜在的新出现呼吸道疾病的病理生理机制、发病率、诊断和影响。
